← All updates
Observational study

Neurology · Obstetrics & Gynecology · 1 h ago

Menopause-associated blood protein changes linked to cognitive ageing and dementia risk

An observational study profiled serum proteins in 80 women aged 35–60 years across menopausal stages who were not using menopausal hormone therapy. Menopause-associated protein changes tracked more closely with sex hormones than age, with additional cohorts linking the proteomic pattern to less favourable cognitive outcomes.

Menopause-associated serum protein changes were linked to cognitive ageing and dementia risk in research summarized by Nature Reviews Neurology. The study included 80 women aged 35–60 years in premenopausal, perimenopausal or postmenopausal stages, none using menopausal hormone therapy. Proteomic profiling identified changes involving inflammatory, synaptic, metabolic and Alzheimer disease-related processes. These changes aligned more strongly with sex hormones than with chronological age. Validation in additional cohorts showed a consistent association between the menopause-associated proteome and less favourable cognitive outcomes. The findings suggest a biological link between menopausal changes and brain health, but the reported associations do not establish causality or demonstrate benefits from hormone therapy. The available preview provides no effect estimates, validation-cohort sizes or detailed cognitive outcome definitions, limiting assessment of clinical significance.

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Sign in to rate this summary →

Source

Nature Reviews Neurology: Menopause-associated proteomic changes link to brain ageing and dementia risk ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.